Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1984 2
1991 2
1994 1
1995 2
1996 1
2000 2
2001 1
2003 1
2004 1
2005 3
2006 3
2007 2
2008 1
2009 8
2010 5
2011 5
2012 3
2013 5
2014 9
2015 12
2016 26
2017 24
2018 27
2019 27
2020 32
2021 61
2022 65
2023 13
Text availability
Article attribute
Article type
Publication date

Search Results

306 results
Results by year
Filters applied: . Clear all
Page 1
'Long COVID' syndrome.
Taribagil P, Creer D, Tahir H. Taribagil P, et al. Among authors: tahir h. BMJ Case Rep. 2021 Apr 19;14(4):e241485. doi: 10.1136/bcr-2020-241485. BMJ Case Rep. 2021. PMID: 33875508 Free PMC article.
Current status of beta-thalassemia and its treatment strategies.
Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, Mughal TA, Hassan A, Kazmi SAR, Sadia, Irfan M, Khan MA. Ali S, et al. Among authors: tahir hm. Mol Genet Genomic Med. 2021 Dec;9(12):e1788. doi: 10.1002/mgg3.1788. Epub 2021 Nov 5. Mol Genet Genomic Med. 2021. PMID: 34738740 Free PMC article. Review.
Cosmetic Applications of Bee Venom.
El-Wahed AAA, Khalifa SAM, Elashal MH, Musharraf SG, Saeed A, Khatib A, Tahir HE, Zou X, Naggar YA, Mehmood A, Wang K, El-Seedi HR. El-Wahed AAA, et al. Among authors: tahir he. Toxins (Basel). 2021 Nov 18;13(11):810. doi: 10.3390/toxins13110810. Toxins (Basel). 2021. PMID: 34822594 Free PMC article. Review.
Biosynthesis and industrial applications of α-amylase: a review.
Farooq MA, Ali S, Hassan A, Tahir HM, Mumtaz S, Mumtaz S. Farooq MA, et al. Among authors: tahir hm. Arch Microbiol. 2021 May;203(4):1281-1292. doi: 10.1007/s00203-020-02128-y. Epub 2021 Jan 22. Arch Microbiol. 2021. PMID: 33481073 Review.
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy.
Oldroyd AGS, Lilleker JB, Amin T, Aragon O, Bechman K, Cuthbert V, Galloway J, Gordon P, Gregory WJ, Gunawardena H, Hanna MG, Isenberg D, Jackman J, Kiely PDW, Livermore P, Machado PM, Maillard S, McHugh N, Murphy R, Pilkington C, Prabu A, Rushe P, Spinty S, Swan J, Tahir H, Tansley SL, Truepenny P, Truepenny Y, Warrier K, Yates M, Papadopoulou C, Martin N, McCann L, Chinoy H; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Oldroyd AGS, et al. Among authors: tahir h. Rheumatology (Oxford). 2022 May 5;61(5):1760-1768. doi: 10.1093/rheumatology/keac115. Rheumatology (Oxford). 2022. PMID: 35355064 Free PMC article. No abstract available.
Aging and its treatment with vitamin C: a comprehensive mechanistic review.
Mumtaz S, Ali S, Tahir HM, Kazmi SAR, Shakir HA, Mughal TA, Mumtaz S, Summer M, Farooq MA. Mumtaz S, et al. Among authors: tahir hm. Mol Biol Rep. 2021 Dec;48(12):8141-8153. doi: 10.1007/s11033-021-06781-4. Epub 2021 Oct 15. Mol Biol Rep. 2021. PMID: 34655018 Review.
Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study.
Mease PJ, Landewé R, Rahman P, Tahir H, Singhal A, Boettcher E, Navarra S, Readie A, Mpofu S, Delicha EM, Pricop L, van der Heijde D. Mease PJ, et al. Among authors: tahir h. RMD Open. 2021 Jul;7(2):e001600. doi: 10.1136/rmdopen-2021-001600. RMD Open. 2021. PMID: 34330846 Free PMC article. Clinical Trial.
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial.
Mease PJ, Smolen JS, Behrens F, Nash P, Liu Leage S, Li L, Tahir H, Gooderham M, Krishnan E, Liu-Seifert H, Emery P, Pillai SG, Helliwell PS; SPIRIT H2H study group. Mease PJ, et al. Among authors: tahir h. Ann Rheum Dis. 2020 Jan;79(1):123-131. doi: 10.1136/annrheumdis-2019-215386. Epub 2019 Sep 28. Ann Rheum Dis. 2020. PMID: 31563894 Free PMC article. Clinical Trial.
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52.
Smolen JS, Mease P, Tahir H, Schulze-Koops H, de la Torre I, Li L, Hojnik M, Sapin C, Okada M, Caporali R, Gratacós J, Goupille P, Liu Leage S, Pillai S, Nash P. Smolen JS, et al. Among authors: tahir h. Ann Rheum Dis. 2020 Oct;79(10):1310-1319. doi: 10.1136/annrheumdis-2020-217372. Epub 2020 Jul 13. Ann Rheum Dis. 2020. PMID: 32660977 Free PMC article. Clinical Trial.
306 results